Christopher Hite
CIK 1814238 · EVP & Vice Chairman · last filed 2026-05-08
Christopher Hite is an EVP & Vice Chairman who has filed 15 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for RPRX, was dated May 8, 2026. Across all open-market trades the lifetime net is +$2.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $42.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$42.77M
4
15
$1.96M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPRX | EVP & Vice Chairman | 779,399 | $54.87 | $42.77M | $1.96M | 10 | 2026-05-08 |
| KLRA | Director | — | — | — | $0 | 1 | 2026-04-20 |
| VERA | Director | — | $34.26 | — | $0 | 1 | 2026-03-09 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 0 | $178.75 | $0 | $0 | 3 | 2021-11-22 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-08 | RPRX | Grant (A) | +24,263 | $0 | EDGAR |
| 2026-04-20 | KLRA | Grant (A) | — | $0 | EDGAR |
| 2026-03-09 | VERA | Grant (A) | — | $0 | EDGAR |
| 2026-02-13 | RPRX | Grant (A) | +26,626 | $0 | EDGAR |
| 2025-11-07 | RPRX | Grant (A) | +6,168 | $0 | EDGAR |
| 2025-08-08 | RPRX | Grant (A) | +3,696 | $0 | EDGAR |
| 2025-05-20 | RPRX | Grant (A) | — | $0 | EDGAR |
| 2025-05-09 | RPRX | Grant (A) | +48,646 | $0 | EDGAR |
| 2025-02-18 | RPRX | Conv (C) | +300,000 | $0 | EDGAR |
| 2024-05-16 | RPRX | Conv (C) | +300,000 | $0 | EDGAR |